The candidate must possess a Ph.D. in one of the following disciplines: Chemistry, specifically synthetic inorganic, synthetic organic, or synthetic organometallic chemistry
Strong synthetic background, especially as it relates to the handling of air-sensitive compounds
Proficiency in using NMR spectroscopy, x-ray crystallography and other analytical techniques such as GC-MS, HPLC, UV-Vis and IR spectroscopy, TGA/DSC.
History of collaboration with cross-disciplinary academic and/or industrial partners
Three (3) or more 1st author publications in high-impact chemistry journals (e.g. JACS, Angew. Chem. Int. Ed., Inorganic Chemistry, Adv. Mat., etc.)
Willingness to apply academic background to semiconductor industry
Unrestricted right to work in the US without requiring sponsorship.In one sense, I think this is a silly preference. What if they were a 2nd author? Co-first author? (what a ridiculous designation, incidentally.)
In another sense, if Intel informally has these sorts of guidelines, by all means, I think that they should make them clear.
(Do pharma companies do this? I feel like the answer is "no", but I could be wrong.)